FOXB1 activators are a specialized group of compounds designed to increase the activity of the FOXB1 protein, a transcription factor known for its role in the regulation of gene expression crucial for development and cell differentiation. The development of these activators involves a meticulous process that starts with an in-depth understanding of the FOXB1 protein structure, its DNA-binding characteristics, and the downstream effects of its activation on gene expression. Initial efforts to identify compounds that can act as FOXB1 activators typically involve high-throughput screening (HTS) techniques. These techniques assess thousands of small molecules for their ability to enhance FOXB1's transcriptional activity, either by increasing its binding affinity to DNA, stabilizing its active form, or facilitating its interaction with co-activators. This screening process is essential for identifying molecules with the potential to positively modulate FOXB1 activity.
Following the identification of promising activators, structure-activity relationship (SAR) studies are conducted to refine these molecules. SAR studies are crucial for determining how specific modifications to the chemical structure of a compound affect its ability to activate FOXB1. Through systematic modifications and subsequent testing, researchers can enhance the potency, selectivity, and bioavailability of these compounds. Additionally, techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are employed to obtain detailed insights into the interactions between FOXB1 and these activators at the molecular level. Understanding these interactions enables researchers to precisely tailor compounds to improve their efficacy as FOXB1 activators. Concurrently, cellular assays are used to validate the functional impact of these compounds, ensuring they effectively induce FOXB1 activity in a biological context and elicit the desired gene expression changes. This comprehensive approach, combining chemical synthesis, molecular biology, and cellular biology techniques, enables the development of effective FOXB1 activators, providing valuable tools for exploring the physiological and pathological roles of FOXB1 in gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methylation inhibitor may cause demethylation of gene promoters, potentially leading to increased transcription of genes, including FOXB1. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
As a histone deacetylase inhibitor, valproic acid could enhance gene expression by altering chromatin structure, potentially affecting FOXB1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By increasing cAMP levels, forskolin can activate PKA, which might lead to changes in transcription factor activity and gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
It regulates gene expression and cellular differentiation, which could include upregulation of transcription factors like FOXB1. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
Vitamin C is an epigenetic modulator that can influence DNA demethylation, potentially impacting the expression of various genes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
This hormone binds to estrogen receptors that can act as transcription factors, potentially influencing FOXB1 expression in responsive tissues. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylases, may lead to a more relaxed chromatin structure and affect gene expression. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
As a stable analog of cAMP, this compound can engage in signaling pathways that regulate transcriptional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This histone deacetylase inhibitor can change chromatin accessibility, possibly affecting the transcription of numerous genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG can modulate epigenetic markers, potentially leading to changes in gene expression profiles. |